
Global Stemgenn Therapy & Research Private Limited
Founded in 2015 and headquartered in Delhi, India.
Founded in 2015 and headquartered in Delhi, India.
East Delhi, Delhi, India
+91-XXXXXXXXXX
U74999DL2015PTC278022
278022
Private Limited Indian Non-Government Company
17 Mar 2015
29 Sep 2018
31 Mar 2018
Unlisted
Roc-Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yogesh Aggarwala ![]() | Additional Director | 24-Mar-2015 | Current |
Sharda Jain ![]() | Director | 17-Mar-2015 | Current |
Global Stemgenn Therapy & Research Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 22.32% decrease. The company also saw a substantial improvement in profitability, with a 93.3% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth | |||||||
EBITDA |
|
In 2017, Global Stemgenn Therapy & Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sharda Jain is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Global Stemgenn Therapy & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Global Stemgenn Therapy & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Stemgenn Therapy & Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Global Stemgenn Therapy & Research Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Global Stemgenn Therapy & Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with RoC-Delhi.
Yogesh Aggarwala was appointed as a Additional Director was appointed as a Additional Director on 24 Mar 2015 & has been associated with this company since 9 years 11 months .
Sharda Jain was appointed as a Director was appointed as a Director on 17 Mar 2015 & has been associated with this company since 9 years 11 months .
Global Stemgenn Therapy & Research Private Limited was registered on 17 Mar 2015 with RoC-Delhi & aged 9 years 11 months as per MCA records.
Global Stemgenn Therapy & Research Private Limited was incorporated on 17 Mar 2015.
The authorized share capital of Global Stemgenn Therapy & Research Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Global Stemgenn Therapy & Research Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Global Stemgenn Therapy & Research Private Limited is 11 Basement Gagan Vihar, New Delgi East Delhi, India, 110051.
The corporate identification number (CIN) of Global Stemgenn Therapy & Research Private Limited is U74999DL2015PTC278022 and the company number is 278022 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2017, the revenue trend for Global Stemgenn Therapy & Research Private Limited has fallen by -22.32%.
The most recent Balance Sheet for Global Stemgenn Therapy & Research Private Limited was filed with the ROC on 31 Mar 2018.
RJ
RD
PM
IT